Quest Diagnostics
DGX
#950
Rank
โ‚น2.465 T
Marketcap
โ‚น22,342
Share price
0.07%
Change (1 day)
36.75%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2026 (TTM): โ‚น129.09 Billion

According to Quest Diagnostics 's latest financial reports the company's current earnings are โ‚น11.56 Billion. In 2025 the company made an earning of โ‚น127.49 Billion, an increase over its 2024 earnings that were of โ‚น113.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น129.09 B1.26%
2025 โ‚น127.49 B12.17%
2024 โ‚น113.65 B3.98%
2023 โ‚น109.30 B-8.5%
2022 โ‚น119.46 B-52.48%
2021 โ‚น251.40 B37.95%
2020 โ‚น182.23 B75.09%
2019 โ‚น104.08 B16.2%
2018 โ‚น89.57 B-10.1%
2017 โ‚น99.63 B-5.16%
2016 โ‚น105.04 B-1.54%
2015 โ‚น106.69 B31%
2014 โ‚น81.44 B-37.52%
2013 โ‚น130.36 B26.93%
2012 โ‚น102.70 B24.01%
2011 โ‚น82.82 B-27.7%
2010 โ‚น114.56 B-3.55%
2009 โ‚น118.77 B19.59%
2008 โ‚น99.32 B12.54%
2007 โ‚น88.25 B-11.7%
2006 โ‚น99.94 B13.49%
2005 โ‚น88.06 B9.02%
2004 โ‚น80.78 B13.19%
2003 โ‚น71.36 B36.03%
2002 โ‚น52.46 B63.07%
2001 โ‚น32.17 B65.49%
2000 โ‚น19.44 B1297.84%
1999 โ‚น1.39 B-73.37%
1998 โ‚น5.22 B-384.21%
1997 -โ‚น1.84 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
LabCorp
LH
โ‚น141.31 B 4.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น4.03 B-97.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น0.19 Billion-100.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น5.03 Billion-103.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น48.48 B-64.30%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น0.76 Billion-100.56%๐Ÿ‡บ๐Ÿ‡ธ USA